ZLAB Zai Lab Ltd
Nasdaq · SEC CIK 1704292 · EDGAR
- Bought, last 12 months
- $65.8K 2 purchases by 1 insiders
- Sold, last 12 months
- $11.13M 35 sales by 6 insiders
- Filings on record
- 235 since 2021-07-02, latest 2026-08-21 16:16
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Du Ying | COB, CEO, Dir | — | $8.58M |
| Edmondson Frazor Titus III | CLO | — | $1.01M |
| Amado Rafael | See Remarks | — | $675.0K |
| Lis William | Dir | — | $340.0K |
| Smiley Joshua L | See Remarks | — | $294.3K |
| Chen Yajing | CFO | — | $239.3K |
| GAYNOR RICHARD | Dir | $65.8K | — |
| Leung Nisa | Dir | — | — |
| Vounatsos Michel | Dir | — | — |
| Morrison Scott W | Dir | — | — |
Transactions 321
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-03 | 2024-04-02 | ZLAB | Reinhart Harald | See Remarks | S - Sale+OE | $16.15 | -1,773 | 49.0K | -3% | -$28.6K |
| DM | 2024-04-03 | 2024-04-01 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | $16.72 | +4,348 | 49.4K | +10% | +$72.7K |
| T | 2024-03-19 | 2024-03-15 | ZLAB | Edmondson Frazor Titus III | CLO | S - Sale | $18.71 | -10.0K | 20.0K | -33% | -$187.1K |
| T | 2024-03-19 | 2024-03-15 | ZLAB | Amado Rafael | See Remarks | S - Sale | $18.86 | -2,544 | 20.1K | -11% | -$48.0K |
| M | 2024-03-15 | 2024-03-13 | ZLAB | Du Ying | COB, CEO, Dir | G - Gift | $0.00 | -33.9K | 1.10M | -3% | $0 |
| T | 2024-03-04 | 2024-03-01 | ZLAB | Smiley Joshua L | See Remarks | P - Purchase | $20.83 | +3,000 | 23.5K | +15% | +$62.5K |
| D | 2024-01-03 | 2024-01-02 | ZLAB | Amado Rafael | See Remarks | S - Sale+OE | $26.30 | -19.4K | 22.6K | -46% | -$509.2K |
| DM | 2024-01-03 | 2023-12-29 | ZLAB | Amado Rafael | See Remarks | M - OptEx | — | +42.0K | 42.0K | New | — |
| D | 2024-01-03 | 2024-01-01 | ZLAB | Du Ying | COB, CEO, Dir | M - OptEx | — | +31.6K | 1.14M | +3% | — |
| D | 2024-01-03 | 2024-01-03 | ZLAB | Du Ying | COB, CEO, Dir | S - Sale+OE | $26.12 | -8,380 | 1.13M | -0.7% | -$218.9K |
| D | 2024-01-03 | 2024-01-03 | ZLAB | Edmondson Frazor Titus III | CLO | S - Sale+OE | $26.12 | -4,803 | 30.0K | -14% | -$125.5K |
| D | 2024-01-03 | 2024-01-01 | ZLAB | Edmondson Frazor Titus III | CLO | M - OptEx | — | +17.5K | 34.8K | +102% | — |
| D | 2024-01-03 | 2024-01-03 | ZLAB | Reinhart Harald | See Remarks | S - Sale+OE | $26.12 | -4,803 | 46.1K | -9% | -$125.5K |
| D | 2024-01-03 | 2024-01-01 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | — | +17.5K | 50.9K | +53% | — |
| T | 2023-12-18 | 2023-12-14 | ZLAB | Smiley Joshua L | See Remarks | P - Purchase | $29.90 | +4,000 | 20.5K | +24% | +$119.6K |
| T | 2023-11-16 | 2023-11-16 | ZLAB | Smiley Joshua L | See Remarks | P - Purchase | $26.93 | +5,000 | 16.5K | +43% | +$134.7K |
| D | 2023-11-03 | 2023-11-01 | ZLAB | Chen Yajing | CFO | M - OptEx | — | +500 | 7,147 | +8% | — |
| D | 2023-11-03 | 2023-11-02 | ZLAB | Chen Yajing | CFO | S - Sale+OE | $25.23 | -165 | 6,982 | -2% | -$4,163 |
| D | 2023-10-03 | 2023-09-29 | ZLAB | Chen Yajing | CFO | M - OptEx | — | +920 | 6,954 | +15% | — |
| D | 2023-10-03 | 2023-09-29 | ZLAB | Chen Yajing | CFO | F - Tax | $24.31 | -307 | 6,647 | -4% | -$7,463 |
| D | 2023-08-21 | 2023-08-17 | ZLAB | Edmondson Frazor Titus III | CLO | F - Tax | $23.39 | -1,181 | 17.3K | -6% | -$27.6K |
| D | 2023-08-21 | 2023-08-17 | ZLAB | Edmondson Frazor Titus III | CLO | M - OptEx | — | +4,850 | 18.4K | +36% | — |
| D | 2023-08-17 | 2023-08-15 | ZLAB | Smiley Joshua L | See Remarks | F - Tax | $24.52 | -4,373 | 11.5K | -28% | -$107.2K |
| D | 2023-08-17 | 2023-08-15 | ZLAB | Smiley Joshua L | See Remarks | M - OptEx | — | +15.9K | 15.9K | New | — |
| 2023-06-30 | 2023-06-29 | ZLAB | Lis William | Dir | A - Grant | $26.45 | +18.9K | 42.2K | +81% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | Chen Kai-Xian | Dir | A - Grant | $26.45 | +18.9K | 49.9K | +61% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | GAYNOR RICHARD | Dir | A - Grant | $26.45 | +18.9K | 27.8K | +212% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | DIEKMAN JOHN D | Dir | A - Grant | $26.45 | +18.9K | 86.5K | +28% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | Morrison Scott W | Dir | A - Grant | $26.45 | +18.9K | 26.2K | +257% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | MOULDER LEON O JR | Dir | A - Grant | $26.45 | +18.9K | 40.5K | +87% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | WIRTH PETER | Dir | A - Grant | $26.45 | +18.9K | 361.7K | +6% | +$500.0K | |
| 2023-06-30 | 2023-06-29 | ZLAB | Du Ying | COB, CEO, Dir | A - Grant | $26.45 | +71.9K | 1.11M | +7% | +$1.90M | |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Edmondson Frazor Titus III | CLO | M - OptEx | $25.30 | +14.6K | 36.5K | +67% | +$369.4K |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Edmondson Frazor Titus III | CLO | F - Tax | $25.30 | -3,556 | 33.0K | -10% | -$90.0K |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Reinhart Harald | See Remarks | F - Tax | $25.30 | -7,182 | 33.3K | -18% | -$181.7K |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | $25.30 | +18.2K | 40.5K | +82% | +$461.7K |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Du Ying | COB, CEO, Dir | F - Tax | $25.30 | -23.1K | 1.08M | -2% | -$585.4K |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Du Ying | COB, CEO, Dir | M - OptEx | $25.30 | +58.8K | 1.06M | +6% | +$1.49M |
| DM | 2023-04-05 | 2023-04-03 | ZLAB | Cho William Ki Chul | CFO | M - OptEx | $0.00 | +2,827 | 53.7K | +6% | $0 |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Du Ying | COB, CEO, Dir | M - OptEx | $33.26 | +14.2K | 1.01M | +1% | +$472.3K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Du Ying | COB, CEO, Dir | F - Tax | $33.26 | -5,588 | 996.2K | -0.6% | -$185.9K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Edmondson Frazor Titus III | CLO | F - Tax | $33.26 | -953 | 21.9K | -4% | -$31.7K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Edmondson Frazor Titus III | CLO | M - OptEx | $33.26 | +3,500 | 22.7K | +18% | +$116.4K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Reinhart Harald | See Remarks | F - Tax | $33.26 | -1,059 | 19.7K | -5% | -$35.2K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | $33.26 | +4,348 | 23.1K | +23% | +$144.6K |
| DA | 2023-03-08 | 2023-03-06 | ZLAB | Du Ying | COB, CEO, Dir | F - Tax | $40.55 | -120.9K | 994.1K | -11% | -$4.90M |
| DMA | 2023-03-08 | 2023-03-03 | ZLAB | Du Ying | COB, CEO, Dir | G - Gift | $0.00 | -852 | 815.4K | -0.1% | $0 |
| DA | 2023-03-08 | 2023-03-06 | ZLAB | Du Ying | COB, CEO, Dir | M - OptEx | $0.6 | +300.0K | 1.11M | +37% | +$180.0K |
| D | 2023-03-07 | 2023-03-03 | ZLAB | Reinhart Harald | See Remarks | S - Sale+OE | $40.00 | -11.5K | 19.0K | -38% | -$459.2K |
| D | 2023-03-07 | 2023-03-03 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | $3.00 | +11.5K | 30.4K | +61% | +$34.4K |
| DM | 2023-03-07 | 2023-03-03+ | ZLAB | Du Ying | COB, CEO, Dir | G - Gift | $0.00 | -44.0K | 994.1K | -4% | $0 |
| D | 2023-03-07 | 2023-03-06 | ZLAB | Du Ying | COB, CEO, Dir | F - Tax | $0.00 | -120.9K | 994.9K | -11% | $0 |
| D | 2023-03-07 | 2023-03-06 | ZLAB | Du Ying | COB, CEO, Dir | M - OptEx | $0.00 | +300.0K | 1.12M | +37% | $0 |
| 2023-03-07 | 2023-03-03 | ZLAB | Vounatsos Michel | Dir | A - Grant | $0.00 | +18.3K | 18.3K | New | $0 | |
| 2023-03-07 | 2023-03-06 | ZLAB | Edmondson Frazor Titus III | CLO | S - Sale | $40.55 | -7,965 | 19.4K | -29% | -$323.0K | |
| 2023-03-07 | 2023-03-03 | ZLAB | Lis William | Dir | S - Sale | $38.31 | -5,434 | 23.3K | -19% | -$208.2K | |
| D | 2023-01-03 | 2022-12-30 | ZLAB | Amado Rafael | See Remarks | A - Grant | $0.00 | +126.0K | 126.0K | New | $0 |
| 2023-01-03 | 2022-12-30 | ZLAB | Reinhart Harald | See Remarks | F - Tax | $30.70 | -5,903 | 19.0K | -24% | -$181.2K | |
| AI | 2022-12-12 | 2021-12-08 | ZLAB | WIRTH PETER | Dir | P - Purchase | $71.36 | +4,000 | 4,000 | New | +$285.4K |
| I | 2022-12-09 | 2022-12-08 | ZLAB | WIRTH PETER | Dir | S - Sale | $35.33 | -4,000 | 0 | -100% | -$141.3K |
| 2022-12-09 | 2022-12-08 | ZLAB | WIRTH PETER | Dir | S - Sale | $35.37 | -3,852 | 342.8K | -1% | -$136.2K | |
| M | 2022-12-09 | 2022-01-05+ | ZLAB | Du Ying | COB, CEO, Dir | G - Gift | $0.00 | -144.2K | 1.00M | -13% | $0 |
| 2022-12-09 | 2022-04-01 | ZLAB | Du Ying | COB, CEO, Dir | F - Tax | $45.47 | -828 | 979.0K | -0.1% | -$37.6K | |
| I | 2022-12-09 | 2022-01-05 | ZLAB | Du Ying | COB, CEO, Dir | G - Gift | $0.00 | +475 | 475 | New | $0 |
| D | 2022-11-17 | 2022-04-01 | ZLAB | Reinhart Harald | See Remarks | F - Tax | $45.47 | -246 | 24.9K | -1.0% | -$11.2K |
| DM | 2022-11-17 | 2022-11-15 | ZLAB | Reinhart Harald | See Remarks | S - Sale+OE | $40.00 | -1,854 | 24.9K | -7% | -$74.2K |
| D | 2022-11-17 | 2022-11-15 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | $3.00 | +1,854 | 26.7K | +7% | +$5,562 |
| A | 2022-08-22 | 2022-04-01 | ZLAB | Edmondson Frazor Titus III | CLO | F - Tax | $45.47 | -203 | 23.7K | -0.8% | -$9,230 |
| D | 2022-08-19 | 2022-08-17 | ZLAB | Edmondson Frazor Titus III | CLO | M - OptEx | $43.52 | +4,850 | 9,146 | +113% | +$211.1K |
| D | 2022-08-19 | 2022-08-17 | ZLAB | Edmondson Frazor Titus III | CLO | F - Tax | $43.52 | -1,181 | 7,965 | -13% | -$51.4K |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Edmondson Frazor Titus III | CLO | M - OptEx | $0.00 | +830 | 23.9K | +4% | $0 |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Reinhart Harald | See Remarks | M - OptEx | $0.00 | +1,010 | 25.1K | +4% | $0 |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Du Ying | COB, CEO, Dir | M - OptEx | $0.00 | +3,400 | 1.01M | +0.3% | $0 |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Cho William Ki Chul | CFO | M - OptEx | $0.00 | +920 | 50.9K | +2% | $0 |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Sandler Alan B. | Head of Gbl Dev, Oncology | M - OptEx | $0.00 | +1,060 | 29.0K | +4% | $0 |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Liang Yi | CCO, Pres, Greater China | M - OptEx | $0.00 | +730 | 104.8K | +0.7% | $0 |
| A | 2022-02-15 | 2022-01-03 | ZLAB | Chen Kai-Xian | Dir | F - Tax | $62.18 | -1,409 | 31.0K | -4% | -$87.6K |
| 2022-02-07 | 2022-02-04 | ZLAB | DIEKMAN JOHN D | Dir | S - Sale | $50.17 | -1,000 | 67.6K | -1% | -$50.2K | |
| 2022-01-21 | 2022-01-20 | ZLAB | Lis William | Dir | S - Sale | $53.40 | -1,926 | 34.1K | -5% | -$102.8K | |
| 2022-01-04 | 2022-01-03 | ZLAB | MOULDER LEON O JR | Dir | A - Grant | $0.00 | +7,763 | 21.6K | +56% | $0 | |
| 2022-01-04 | 2022-01-03 | ZLAB | Chen Kai-Xian | Dir | A - Grant | $0.00 | +7,763 | 32.4K | +31% | $0 | |
| 2022-01-04 | 2022-01-03 | ZLAB | Lis William | Dir | A - Grant | $0.00 | +7,763 | 36.0K | +27% | $0 | |
| 2022-01-04 | 2022-01-03 | ZLAB | DIEKMAN JOHN D | Dir | A - Grant | $0.00 | +7,763 | 68.6K | +13% | $0 | |
| 2022-01-04 | 2022-01-03 | ZLAB | WIRTH PETER | Dir | A - Grant | $0.00 | +7,763 | 350.6K | +2% | $0 | |
| 2021-12-30 | 2021-12-29 | ZLAB | Reinhart Harald | See Remarks | F - Tax | $69.23 | -5,903 | 24.1K | -20% | -$408.7K | |
| 2021-12-27 | 2021-12-21 | ZLAB | Reinhart Harald | See remarks | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| 2021-12-08 | 2021-12-08 | ZLAB | WIRTH PETER | Dir | P - Purchase | $71.36 | +4,000 | 342.9K | +1% | +$285.4K | |
| 2021-12-03 | 2021-12-01 | ZLAB | Sandler Alan B. | Head of Gbl Dev, Oncology | F - Tax | $71.23 | -2,075 | 27.9K | -7% | -$147.8K | |
| 2021-12-03 | 2021-08-17 | ZLAB | Edmondson Frazor Titus III | CLO | F - Tax | $140.29 | -1,181 | 23.1K | -5% | -$165.7K | |
| 2021-11-22 | 2021-11-19 | ZLAB | GAYNOR RICHARD | Dir | A - Grant | $0.00 | +8,912 | 8,912 | New | $0 | |
| 2021-11-08 | 2021-11-05 | ZLAB | DIEKMAN JOHN D | Dir | S - Sale | $91.65 | -1,000 | 60.9K | -2% | -$91.7K | |
| MI | 2021-10-29 | 2021-10-28 | ZLAB | Fu Tao | Pres, COO, Dir | S - Sale | $105.00 | -10.0K | 85.4K | -10% | -$1.05M |
| 2021-10-18 | 2021-10-18 | ZLAB | Morrison Scott W | Dir | A - Grant | $0.00 | +7,345 | 7,345 | New | $0 | |
| MI | 2021-10-14 | 2021-10-14 | ZLAB | Fu Tao | Pres, COO, Dir | S - Sale | $102.68 | -10.0K | 87.5K | -10% | -$1.03M |
| MI | 2021-10-01 | 2021-09-30 | ZLAB | Fu Tao | Pres, COO, Dir | S - Sale | $106.73 | -10.0K | 97.8K | -9% | -$1.07M |
| 2021-09-27 | 2021-09-15 | ZLAB | Fu Tao | Pres, COO, Dir | S - Sale | $134.09 | -100 | 207.5K | -0.0% | -$13.4K | |
| 2021-09-27 | 2021-09-24 | ZLAB | Fu Tao | Pres, COO, Dir | F - Tax | $119.86 | -19.8K | 187.7K | -10% | -$2.38M | |
| 2021-09-22 | 2021-09-20 | ZLAB | Leung Nisa | Dir | J - Other | $0.00 | +63.1K | 63.1K | New | $0 | |
| I | 2021-09-22 | 2021-09-20 | ZLAB | Leung Nisa | Dir | J - Other | $0.00 | -1.15M | 7.92M | -13% | $0 |
| DM | 2021-09-16 | 2021-09-15 | ZLAB | Fu Tao | Pres, COO, Dir | S - Sale+OE | $127.86 | -9,900 | 209.3K | -5% | -$1.27M |
Purchase Sale Sale after option exercise All abbreviations